CompoAtlas

NUTRILITE™ Augļu un Dārzeņu Koncentrāts (Paziņots 2010.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000534/2017
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
Amway Polska Sp. z o.o.
Manufacturer
Access Business Group LLC
Origin
Polija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
2 tabletes dienā
Published pack size
tabletes pa 0,51 g
Published packaging
60 tabletes

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
Zaļās tējas lapu ekstraktsplants ; Zaļās tējas lapu ekstrakts ; Camellia sinensis ; 248 ; mgcamellia sinensisPlant
Granātābolu augļu ekstraktsplants ; Granātābolu augļu ekstrakts ; Punica granatum ; 110 ; mgpunica granatumPlant
Apelsīnu augļu ekstraktsplants ; Apelsīnu augļu ekstrakts ; Citrus sinensis ; 98 ; mgcitrus sinensisPlant
Plūškoka augļu ekstraktsplants ; Plūškoka augļu ekstrakts ; Sambucus nigra ; 16 ; mgsambucus nigraPlant
Zileņu koncentrātsplants ; Zileņu koncentrāts ; Vaccinium corymbosum ; 12 ; mgvaccinium corymbosumPlant
Rozmarīna lapu ekstraktsplants ; Rozmarīna lapu ekstrakts ; Rosmarinus officinalis ; 20 ; mgrosmarinus officinalisPlant
Acerolas augļu koncentrātsplants ; Acerolas augļu koncentrāts ; Malpighia emarginata ; 12 ; mgmalpighia emarginataPlant
Brokoļu koncentrātsplants ; Brokoļu koncentrāts ; Brassica oleracea ; 10 ; mgbrassica oleraceaPlant
Burkānu koncentrātsplants ; Burkānu koncentrāts ; Daucus carota ; 10 ; mgBêta-carotèneVitamin or mineral
Spinātu lapu koncentrātsplants ; Spinātu lapu koncentrāts ; Spinacia oleracea ; 10 ; mgspinacia oleraceaPlant
Mikrokristāliskā celuloze (E 460)otherIngredients ; Mikrokristāliskā celuloze (E 460)Listed as food additive E 460(i) (EU Union list)Role not identified
Hidroksipropilmetilceluloze (E 464)otherIngredients ; Hidroksipropilmetilceluloze (E 464)Listed as food additive E 464 (EU Union list)Role not identified
MaltodekstrīnsotherIngredients ; MaltodekstrīnsNot recognisedRole not identified
Silīcija dioksīds (E 551)otherIngredients ; Silīcija dioksīds (E 551)Listed as food additive E 551 (EU Union list)Role not identified
ŽelatīnsotherIngredients ; ŽelatīnsNot recognisedRole not identified
Kukurūzas eļļaotherIngredients ; Kukurūzas eļļaNot recognisedRole not identified
Kukurūzas cieteotherIngredients ; Kukurūzas cieteNot recognisedRole not identified
SaharozeotherIngredients ; SaharozeNot recognisedRole not identified
Glicerīns (E 422)otherIngredients ; Glicerīns (E 422)Listed as food additive E 422 (EU Union list)Role not identified
Karnaubvasks (E 903)otherIngredients ; Karnaubvasks (E 903)Listed as food additive E 903 (EU Union list)Role not identified
Taukskābes (E 570)otherIngredients ; Taukskābes (E 570)Listed as food additive E 570 (EU Union list)Role not identified
Likopēns (no tomātu ekstrakta)otherIngredients ; Likopēns (no tomātu ekstrakta) ; 3,1 ; mgNot recognisedRole not identified
Akācijas sveķi (E 414)otherIngredients ; Akācijas sveķi (E 414)Listed as food additive E 414 (EU Union list)Role not identified
Šķērsšūtās karboksimetilcelulozes nātrija sāls (E 468)otherIngredients ; Šķērsšūtās karboksimetilcelulozes nātrija sāls (E 468)Listed as food additive E 468 (EU Union list)Role not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Amerikas Savienotās Valstis

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Granātābolu augļu ekstrakts
    Read the warning, when it applies and the studies cited
  • Plūškoka augļu ekstrakts
    Read the warning, when it applies and the studies cited

    ELDER – SAMBUCUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).

    Sources cited by Health Canada (1)
    • Förster-Waldl E, Marchetii M, Schöll I, Focke M, Radauer C, Kinaciyan T, Nentwich I, Jäger S, Schmid ER, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E. Type I allergy to elderberry (Sambucus nigra) is elicited by a 33.2 kDa allergen with significant homology to ribosomal inactivating proteins. Clinical and Experimental Allergy 2003;33(2):1703-1710. PubMed

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines. 3rd edition. London (GB): The Pharmaceutical Press; 2007.
    • Winston D and Kuhn MA. Herbal Therapy & Supplements A Scientific and Traditional Approach. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

  • Zileņu koncentrāts
    Read the warning, when it applies and the studies cited

    Blueberry

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing 5 grams or more of total dried fruit, per day; Products providing 37.5 grams or more of total fresh fruit, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (ASHP 2005; Franco et al. 2004; IOM 2001; Hansten et al. 1997).

    Sources cited by Health Canada (4)
    • ASHP 2005: American Society of Health-System Pharmacists. American Hospital Formulary Service (AHFS) Drug Information. Philadelphia (PA): Lippincott Williams and Wilkins; 2005.
    • Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. The American Journal of Medicine 2004;166(10):651-656. PubMed Randomised trial
    • Hansten PD, Horn JR, editors. Drug Interactions Analysis and Management. Vancouver (WA): Applied Therapeutics Inc.; 1997.
    • IOM 2001: Institute of Medicine. Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington (DC): National Academies Press; 2001.

    Health Canada monograph dated 29 August 2025

  • Rozmarīna lapu ekstrakts
    Read the warning, when it applies and the studies cited

    ROSEMARY – ROSMARINUS OFFICINALIS Oral

    Route of administration: Oral (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association’s Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 29 May 2026

    ROSEMARY - ROSMARINUS OFFICINALIS Topical

    Route of administration: Topical (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association’s Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have large open wounds, skin lesions, feverish conditions, acute inflammation, severe circulatory disorders or hypertension (ESCOP 2003).

    Sources cited by Health Canada (1)
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Barnes et al. 2007; ESCOP 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Health Canada monograph dated 29 May 2026

  • Burkānu koncentrāts
    Read the warning, when it applies and the studies cited

    CARROT - DAUCUS CAROTA SUBSP. SATIVUS

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing more than 6,000 μg of beta-carotene, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are a tobacco smoker (Touvier et al. 2005; Omenn et al. 1996; ATBC 1994).

    Sources cited by Health Canada (3)
    • ATBC (Alpha-tocopherol, beta-carotene cancer prevention) study group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The New England Journal of Medicine1994;330(15):1029-1035.
    • Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine 1996;334(18):1150-1155. PubMed Randomised trial
    • Touvier M, Kess E, Clavel-Chapelon F, and Boutron-Rualt MC. Dual association of beta- carotene with risk of tobacco-related cancers in a cohort of French women. Journal of the National Cancer Institute 2005;97(18):1338-1344. PubMed

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “NUTRILITE™ Augļu un Dārzeņu Koncentrāts (Paziņots 2010.)”, https://compoatlas.com/en/supplements/latvia/6636-nutrilitetm-auglu-un-darzenu-koncentrats-pazinots-2010, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line